AGP Executive Report
Last update: 2 hours agoIVF Access in Europe: A new ESHRE 2026 “cost-to-baby” analysis says cutting out-of-pocket IVF costs by half could more than double live births (2.67x), pointing to affordability—not technology—as the main barrier to parenthood. Fertility Trends: Europe also hit a record 2023 volume of ART cycles (1.16M) and births (247k), but the record still masks who can afford treatment. Neurology Treatment in DACH: Real-world data from Innsbruck suggests tiapride for Huntington disease chorea leads to fewer adverse-effect discontinuations than tetrabenazine, supporting symptomatic care choices in Germany/Austria/Switzerland. Public Health Alert: ECDC reports the DRC Ebola outbreak has reached 1,561 confirmed cases and 506 deaths, with preparedness steps triggered after a doctor returned from the region tested positive in France. Healthcare Tech: Longeviti Neuro Solutions launched ClearFit AI™ and a brain ultrasound interface concept aimed at bedside neuro imaging to reduce reliance on CT/MRI transport. Policy Pressure on Sick Leave: Germany’s planned crackdown—requiring doctor proof from day one and ending phone-in sick notes—sparks debate over productivity versus worker health impacts.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.